Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PALI Palisade Bio, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.69 +6.3% | $15.82 +5.0% |
| StockIQ Score | 42D Weak Risk: High | 38F Weak Risk: Medium |
| Technical | 5F | 21F |
| Fundamental | 46D+ | 35F |
| Growth | 52C- | 50C- |
| Fair Value | 55C | 38F |
| News | 80A- | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
PALI has a higher overall investor score (63) than AAPG (37) and a much stronger technical score (85 vs 18). Its fundamental (46 vs 35), valuation (55 vs 38) and growth scores (52 vs 50) also exceed AAPG's, though the growth gap is small. Overall, PALI appears stronger across most categories.
